MH

Price has broken down below near-term EMAs and the 50-day SMA, indicating weakening momentum and susceptibility to further decline. Medium-term structure supports a bearish bias, and short-term timing favors initiating a sell near overhead resistance. Execution should focus on rejection at the 9/20 EMA zone, with attention to potential support bounces.

• ↑Q1 revenue +2.6% YoY to $550M; recurring revenue climbed 9.8% to 77%.
• ↑Adjusted EBITDA margin expanded 192 bps YoY to 37.7%, signaling strong margin leverage.
• ↓Subpar QS score highlights potential profitability and execution inefficiencies.